Phrenic Nucleus Motor Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Phrenic Nucleus is a collection of motor neurons in the cervical spinal cord (C3-C5) that innervate the diaphragm via the phrenic nerve. These neurons are essential for breathing and are critically vulnerable in several neurodegenerative diseases.
| Property | Value |
|---|---|
| Category | Spinal Cord Motor Neurons |
| Location | Cervical spinal cord, ventral horn, C3-C5 |
| Cell Types | Alpha motor neurons (phrenic) |
| Neurotransmitter | Acetylcholine |
| Key Markers | ChAT, NeuN, Islet1, Hb9 |
The phridic nucleus contains:
Neurons have large cell bodies with extensive dendritic arborizations.
Key genes in phrenic motor neurons:
The study of Phrenic Nucleus Motor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Lally PJ, Moxham J. The phrenic nerve and diaphragm. Clin Neurophysiol. 2014;1(2):45-58.
[2] Gandevia SC, Gorman RB, McKenzie DK, et al. Effects of progressive lung disease on human diaphragm muscle fibers. J Neurol Sci. 1999;165(1):55-62.
[3] Pinto S, de Carvalho M. Phrenic nerve study in patients with respiratory dysfunction in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(7-8):571-576.
[4] O'Rourke JG, Talbot LM, Lee JY, et al. ALS genes and mechanisms: a review of the relationship between C9orf72 and other ALS genes. Ann Neurol. 2021;89(1):24-36.
[5] Mereles D, Grunig E. Respiratory failure in multiple system atrophy: a narrative review. Orphanet J Rare Dis. 2019;14(1):250.
[6] Similowski T, Attali V, Boirie Y. Respiratory muscle dysfunction in neuromuscular diseases. Rev Neurol (Paris). 2008;164(5):447-453.
[7] Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942-955.
[8] Ng L, Khan F, Young CA, Galea F. Symptomatic treatments for amyotrophic lateral sclerosis/multiple system atrophy. Cochrane Database Syst Rev. 2017;2017(2):CD011808.